SplitJul 21, 2026, 08:21 AM
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split, Special Dividend
AI Summary
VYNE Therapeutics announced a 1-for-50 reverse stock split of its common stock, approved by stockholders and the board, in connection with its proposed merger with Yarrow Bioscience. The company also declared a special cash dividend of $17.3 million, or approximately $0.40242 per share, payable to stockholders of record as of July 22, 2026. Following the merger, the combined company will trade as Yarrow Bioscience, Inc. under the ticker "YARW".
Key Highlights
- Board approved a 1-for-50 reverse stock split of common stock.
- Special cash dividend of $17.3 million declared, or $0.40242 per share.
- Reverse stock split to reduce outstanding shares from 33.4 million to 0.7 million.
- Stockholders approved increasing authorized shares from 150 million to 300 million.
- Cash dividend record date is July 22, 2026, with payment expected July 23, 2026.
- Merger with Yarrow Bioscience expected to close around July 24, 2026.
- Combined company to trade as Yarrow Bioscience, Inc. (YARW) post-merger.
Price Impact
More from VYNE